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Purpose: Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) is a familial blinding disease of
unknown pathophysiology. The eyes and sera from patients with ADNIV were studied to understand the immune response
in this condition.
Methods: The clinical case of an ADNIV patient was reviewed. Eye specimens from two donors with ADNIV were
examined with a panel of standard histopathological stains and immunohistochemical markers. These findings were
compared to specimens of noninflammatory eye disease. Sera from twelve patients were also tested against retinal protein
western blots for the presence of autoretinal antibodies.
Results: Each of the ADNIV and control eyes showed degenerative features of phthisis bulbi. Immunohistological stains
revealed a supraciliary T-cell infiltrate in ADNIV eyes composed of cluster of differentiation-4 (CD4) positive and cluster
of differentiation-8 (CD8)-positive cells. No immunoglobulin or B cells were detected in these eyes. Inflammatory cells
were absent from the control eyes. No specific autoretinal antibodies were detected in ADNIV sera.
Conclusions: Aberrant T-cell-mediated processes may underlie ADNIV, and therapeutics directed at T cells may better
manage inflammation in these patients. Genes related to T-cell function are high priority screening candidates.
The eye is an immune-privileged site where the local
immunological  mechanisms  are  poorly  understood.
Autosomal  dominant  neovascular  inﬂammatory
vitreoretinopathy (ADNIV) is an autoimmune disease of the
eye without systemic features [1,2]. ADNIV shares several
features with more common vitreoretinal diseases, including
diabetic  retinopathy,  idiopathic  uveitis,  proliferative
vitreoretinopathy, and retinitis pigmentosa.
ADNIV  is  an  eye-speciﬁc  inﬂammatory  condition
characterized by pigmentary retinal degeneration, loss of the
electroretinogram b-wave, and peripheral field loss [1]. This
progressive degeneration is complicated by anterior segment
and vitreous inflammation, retinal neovascularization, retinal
detachment, and eventual phthisis. Cellular infiltrates in the
vitreous are among the earliest detectable signs of ADNIV and
continue throughout the course of the disease. The nature of
the cells is not known.
Despite  photoreceptor  degenerative  changes,  one
hypothesis suggests that ocular autoimmunity is the primary
pathogenic cause of ADNIV and that the cells are either of B-
cell or T-cell origin. Despite organ atrophy in the late stages
of disease, antigens that instigate autoimmune reactions may
still be active. The ADNIV autoimmune reaction continues
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through end-stage disease when the eye becomes shrunken
and blind, and studies in these eyes may still be relevant to
earlier  stages  of  ADNIV.  To  better  understand  ADNIV
pathogenesis,  we  performed  studies  to  detect  autoretinal
antibodies and in the case of ADNIV autopsy eyes detect the
presence of B-cell and T-cell infiltration.
METHODS
Informed consent was obtained to review the case history of
a 80-year-old ADNIV patient examined in the University of
Iowa Department of Ophthalmology clinic. The case history
was reviewed for a first-generation ADNIV patient. We used
six  postmortem  eyes  (University  of  Iowa,  Department  of
Pathology archived tissue collection), that had been received
in  formalin  and  post  fixed  in  Pen-fix  (Thermoscientific,
Waltham, MA). After the eye was opened by pupil–optic
nerve section, it was decalcified. Histological staining with
Masson's Trichrome stain was performed according to the
manufacturer’s  protocol  (Sigma-Aldrich,  St.  Louis,  MO).
Immunohistochemical staining was performed as follows. All
slides were stained on the DAKO Autostainer+ (Carpinteria,
CA),  using  heat  pretreatment  with  a  pressure  cooker.  All
antibodies used Targert Retrieval pH 6.0 (#S1699; DAKO),
except cluster of differentiation-4 (CD4), which used high-pH
retrieval (#S3308; DAKO). The following antibodies were
used: anti-CD3 (#A0452; DAKO) diluted to 1:200; anti-CD4
(#NCL-L-CD4–1F6;  LeicaSystems,  Bannockburn,  IL)
diluted  to  1:40;  anti-CD8  (#M7103;  DAKO)  diluted  to
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10341:1,000; anti-CD20 (#M0755; DAKO) diluted to 1:400; anti-
CD68  (#M0814;  DAKO)  diluted  to  1:400;  and  anti-
immunoglobulin  G  (IgG;  #A0424;  DAKO)  diluted  to
1:40,000. All antibodies were incubated for 30 min. A dual
endogenous enzyme block (DAKO #S2003, Carpinteria, CA)
was used for 5 min. Detection was for 30 min and DAB+
(DAKO #K3467, Carpinteria, CA) was used for 5 min. DAKO
Envision+ Dual-Link labeled polymer (#K4061) was used for
detection.
Autoretinal antibody assay: Following informed consent,
serum was collected from 12 patients with ADNIV (2 males,
and 9 females; age range 7–68) and 12 unaffected, healthy
controls  (3  males,  and  8  females;  age  range  18–74).  The
samples were screened on human retinal lysate to determine
whether these sera contained autoantibodies against retinal
antigens.  Methods  for  western  blot  were  performed,
essentially as described previously [3]. Briefly, human retinal
lysate was pooled from three donor eyes, separated by sodium
dodecyl sulfate PAGE, and transferred to polyvinyldifluoride
membrane. Serum from ADNIV patients or unaffected control
patients without retinal disease was incubated with membrane
strips  to  detect  retinal  antigens  and  visualized  using
horseradish  peroxidase-conjugated  antihuman  secondary
antibody. Results were compared between ADNIV patients
and controls.
RESULTS
Case report: An 80-year-old female originally presented with
idiopathic  posterior  uveitis  and  retinitis  pigmentosa.  She
underwent intracapsular cataract extractions 11 years prior
and had postoperative visual acuity in the 20/200 range. Her
right eye became phthisical 2 years before presentation, at
which time she had a severe uveitis and vitreous hemorrhage
in her left eye. She had no systemic inflammatory diseases,
and  a  posterior  uveitis  workup  was  negative.  Her  family
history suggested a genetic etiology, and she was found to be
related to the original ADNIV pedigree that we first described
in 1990 with similar clinical findings and genetic linkage to
chromosome 11q13 [1,2].
On examination her visual acuity was no light perception
right  eye  and  light  perception  left  eye.  The  intraocular
pressures were 5 and 18 mm Hg, respectively. The anterior
segment  examination  showed  fulminant  iris
neovascularization. The right eye was phthisical with no view
to the posterior pole (Figure 1A). Echography showed reduced
axial length and small size along with a shell-like calcification
of the choroid and dense vitreous opacities with extensive
retinal  detachment  (Figure  1B).  The  left  fundus  revealed
vitreous hemorrhage, pigmentary retinopathy, and peripheral
neovascularization  and  fibrotic  changes  (Figure  1C).  An
electroretinogram  of  the  left  eye  showed  completely
Figure  1.  End-stage  autosomal
dominant  neovascular  inflammatory
vitreoretinopathy.  A:  This  phthisical
right  eye  shows  cloudy  corneas,  iris
neovascularization,  and  pupillary
fibrous membrane with aphakia. B: The
B-scan  demonstrates  a  foreshortened
disorganized  eye  with  total  retinal
detachment  and  calcification.  C:  The
fellow  prephthisical  eye  showed  a
neovascular stalk on the optic disc. D:
Electroretinogram reveals extinguished
photopic and scotopic responses.
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1035extinguished photopic and scotopic response (Figure 1D).
Two  years  later,  the  left  eye  went  into  phthisis,  and
echography  revealed  tractional  retinal  detachment  and
posterior  calcification.  These  clinical  findings  were
characteristic of end-stage disease in several members of the
ADNIV pedigree. When the patient expired, a pathological
examination of the eyes was performed.
Pathology findings: Gross examination of the eyes revealed
shrunken,  firm,  grossly  distorted  globes.  There  were
significant corneal opacities, collapsed anterior chambers, and
a  gray-brown,  irregular,  firm  material  within  the  vitreous
cavities. The retinas and the choroids were detached, with
accumulation of suprachoroidal fluid.
Typical features of phthisis bulbi were apparent on pupil–
optic nerve sections (Figure 2). The cornea and sclera were
thick,  forming  a  shrunken  square  outline.  The  intraocular
contents  were  grossly  disorganized.  An  anterior  hyaloid
fibrovascular connective tissue detached the ciliary body, with
underlying  suprachoroidal  effusions.  The  membrane
extended over the iris and into a collapsed anterior chamber.
Figure 2. Masson’s trichrome stain of
autosomal  dominant  neovascular
inflammatory  vitreoretinopathy
(ADNIV)  eye  demonstrates
fibrovascular proliferation and features
of  phthisis.  A:  There  was  massive
fibrovascular  connective  tissue  within
the pupil, overlying the iris, and causing
detachment of the ciliary body. B: A
supraciliary  effusion  was  present
outside  the  detached  ciliary  body.  C:
The sclera was thickened. D: There were
a  few  lens  remnants  present.  E:  A
fibrovascular  stalk  extended  from  the
optic nerve to the peripheral retina. F:
The retina was detached, atrophic, and
osseous metaplasia was present.
Figure 3. Antiretinal autoantibodies. A:
Control  serum  from  12  subjects  was
applied  to  human  retinal  proteins
separated  by  sodium  dodecyl  sulfate
PAGE.  Nonspecific  banding  patterns
were  detected.  B:  Serum  from  12
autosomal  dominant  neovascular
inflammatory vitreoretinopathy patients
was applied to similar retinal blots, and
no  specific  bands  or  unique  patterns
were detected. The major band in all
samples  indicates  cross-reaction  of
secondary  antibody  with  endogenous
human immunoglobulin G (IgG) chains.
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1036The retinas were atrophic, cystic, and completely detached. A
fibrovascular stalk extended from the disc anteriorly through
a  vitreous  filled  with  proteinacious  exudates  (congo  red
negative, not shown). Osseous metaplasia was present along
the  retinal  pigment  epithelium  and  around  atrophic  optic
nerves. These features were also present in control eyes that
were phthisical from glaucoma, a noninflammatory condition
without continuous autoimmunity found in ADNIV.
Autoretinal  antibodies:  To  determine  whether  systemic
autoretinal antibodies were present in ADNIV patients, serum
Figure 4. B-cell markers were absent in autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) eyes. A: Lymph node
tissue is a positive control for the B-cell marker, cluster of differentiation-20 (CD20), which was shown by the brown color reaction. B-C:
ADNIV supraciliary space and vitreous showed only rare CD20 positive cells. D: Placental tissue is a positive control for immunoglobulin-
G (IgG), which was shown by the brown color reaction. E-F: IgG was rarely detected in ADNIV eyes. The scale bar represents 50 µm.
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1037Figure 5. T-cell markers were detected in autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) eyes. A: Lymph node
tissue is a positive control for the T-cell marker, cluster of differentiation-3 (CD3), which was shown by the brown color reaction. B-C: In
ADNIV eyes, the supraciliary space and vitreous showed CD3 positive cells. D-E: In control (non-ADNIV) phthisical eyes, CD3 positive
cells were absent. F: Lymph node tissue is a positive control for the T-cell marker, cluster of differentiation-4 (CD4), which was shown by
the brown color reaction. G-H: In ADNIV eyes, the supraciliary space and vitreous both showed CD4 positive cells. I-J: In control (non-
ADNIV) phthisical eyes, CD4 positive cells were absent. K: Lymph node tissue is a positive control for the T-cell marker, cluster of
differentiation-8 (CD8), which was shown by the brown color reaction. L: In ADNIV eyes, the supraciliary space showed CD8 positive cells.
M: In the ADNIV vitreous, CD8 positive cells were absent. N-O: In control (non-ADNIV) phthisical eyes, CD8 positive cells were absent.
The scale bar represents 50 μm.
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1038antibodies were applied to retinal protein blots. Sera from 12
control patients without ADNIV and 12 patients with ADNIV
were compared (Figure 3). Although some immunoreactive
bands were present in both the ADNIV and unaffected sera,
no consistent distinct protein band or pattern of bands was
present in the ADNIV subjects when compared to control
samples.
B-cell  and  immunoglobulin  G  immunohistopathology:  A
series of immunohistochemical markers for immune cells was
applied to the ADNIV eyes. Antibody markers for both CD20
(a marker for B lymphocytes) and IgG were applied to the
ADNIV eyes, but no CD20 cells or clusters of IgG were
detected (Figure 4). These markers were also not seen in the
control phthisis eyes.
T-cell  immunohistopathology:  In  the  ADNIV  eyes,  CD3-
positive  (CD3+)  cells  were  detected  within  a  supraciliary
effusion (Figure 5). Such an effusion was not present in the
control eyes. CD3+ cells were also present in the vitreous. To
distinguish these T cells, antibody markers for CD8 and CD4
were applied. Both CD8+ and CD4+ cells were present in the
supraciliary effusion, but only CD4+ cells were found in the
vitreous.
The macrophage marker CD68 was detected infrequently
and did not show expression differences between ADNIV and
control eyes (data not shown).
DISCUSSION
These  findings  support  the  hypothesis  that  an  underlying
ocular  immune  dysfunction  is  present  in  ADNIV.  CD4
expression, which is found predominantly on the surface of
helper T cells, was found in both the vitreous and supraciliary
space. CD8 expression, which is found predominantly on the
surface  of  cytotoxic  T  cells,  was  mostly  restricted  to  the
supraciliary space. By comparison, there were few B cells,
IgG, and no specific antiretinal autoantibodies. This suggests
that  cell-mediated  rather  than  antibody-mediated
autoimmunity may be the primary inflammatory mechanism.
The  genetic  locus  for  ADNIV  was  mapped  to
chromosome  11q13  in  1992  [2],  but  the  causative  gene
remains unknown. These findings suggest genes that function
in T-cell activation could be prioritized in candidate gene
sequencing. For example, one gene in the interval is tumor
necrosis  factor  (TNF)  receptor  superfamily  member  19
(TNFRSF19L), a member of the TNF receptor superfamily,
which can stimulate T-cell proliferation in the presence of
CD3 signaling [4]. Until the causative gene is found and
highly specific therapy can be applied, current management
of ADNIV involves local immunosuppression with periocular
or intraocular Kenalog. This nonspecific therapy might be
optimized by medications directed at the specific mediators
of ADNIV. Our findings suggest that therapeutic strategies
targeting  T  cells  may  be  more  effective  than  nonspecific
therapies or those that target B cells. For example, drugs, such
as cyclosporin A, FK06, anti-CD3, and rapamycin, that target
T-cell activation and downstream T-cell pathways might have
greater effect than B-cell drugs, such as cyclophosphamide,
mycophenylate  mofetil,  anti-inducible  costimulatory
molecule (ICOS), anti-CD20, or anti-CD52 [5]. Like some
other  uveitic  conditions,  ADNIV  eventually  becomes
resistant  to  conventional  steroid  immunosuppression.  It  is
possible  that  steroid  refractory  T  cells  are  present,  and
therapies directed at steroid-independent mechanisms may
overcome this limited response [6].
The main limitation of this study is the few number of
eyes,  but  ADNIV  is  rare  and  there  are  no  previous
histopathological  reports.  The  eyes  in  this  study  were
phthisical  and  represent  late  stage  ADNIV.  Nevertheless,
there is an ongoing autoimmune reaction in this disease, and
phthisis in the ADNIV eye seems to be immunologically
different from that observed in control eyes with phthisis from
other conditions [7,8]. This study provides a basis for future
studies that will test vitreous samples from early stage ADNIV
to confirm the presence of T cells [9].
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